Investigational drugs for treating agitation in persons with dementia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational drugs for treating agitation in persons with dementia
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 25, Issue 8, Pages 973-983
Publisher
Informa UK Limited
Online
2016-05-28
DOI
10.1080/13543784.2016.1193155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isn’t Your Staff Trained To Manage My Mother?
- (2016) Martin Steinberg AMERICAN JOURNAL OF PSYCHIATRY
- Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial
- (2016) Lon S. Schneider et al. AMERICAN JOURNAL OF PSYCHIATRY
- Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program
- (2016) Clive Ballard et al. AMERICAN JOURNAL OF PSYCHIATRY
- Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies
- (2016) Jeffrey Cummings et al. CNS Neuroscience & Therapeutics
- Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries
- (2016) Ricardo P. Garay et al. EXPERT OPINION ON PHARMACOTHERAPY
- Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial
- (2015) Geke A.H. van den Elsen et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- The Burden of Health Care Costs for Patients With Dementia in the Last 5 Years of Life
- (2015) Amy S. Kelley et al. ANNALS OF INTERNAL MEDICINE
- Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease
- (2015) Francesco Panza et al. EXPERT OPINION ON PHARMACOTHERAPY
- Advancements in the treatment of agitation in Alzheimer’s disease
- (2015) Inga M Antonsdottir et al. EXPERT OPINION ON PHARMACOTHERAPY
- The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?
- (2015) Leslie Citrome et al. Expert Review of Neurotherapeutics
- Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be hel
- (2015) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Use of Benzodiazepines in Alzheimer’s Disease: A Systematic Review of Literature
- (2015) Michaela Defrancesco et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia
- (2015) Jeffrey L. Cummings et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial
- (2015) G. A. H. van den Elsen et al. NEUROLOGY
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
- (2015) Davy Vancampfort et al. World Psychiatry
- The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?
- (2015) Leslie Citrome et al. Expert Review of Neurotherapeutics
- Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
- (2015) Uwe K. Zettl et al. Therapeutic Advances in Neurological Disorders
- Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
- (2015) Shinji Matsunaga et al. PLoS One
- Systematic review of recent dementia practice guidelines
- (2014) J. Ngo et al. AGE AND AGEING
- Effects of oral ELND005 (scyllo-inositol) on neuropsychiatric symptoms in a 78-week phase 2 study in mild/moderate Alzheimer's disease (AD): Potential role of myo-inositol reduction
- (2014) Constantine Lyketsos et al. Alzheimers & Dementia
- A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults
- (2014) Leslie Citrome et al. CURRENT MEDICAL RESEARCH AND OPINION
- Bipolar disorder: recent clinical trials and emerging therapies for depressive episodes and maintenance treatment
- (2014) Ricardo P. Garay et al. DRUG DISCOVERY TODAY
- Antiepileptic Drugs for the Treatment of Agitation and Aggression in Dementia: Do They Have a Place in Therapy?
- (2014) Damien Gallagher et al. DRUGS
- Dextromethorphan/Quinidine: A Review of Its Use in Adults with Pseudobulbar Affect
- (2014) Lily P. H. Yang et al. DRUGS
- Investigational drugs for anxiety in patients with schizophrenia
- (2014) Ricardo P Garay et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Can antidepressant medication relieve agitation in Alzheimer’s disease?
- (2014) Anton P Porsteinsson et al. Expert Review of Neurotherapeutics
- Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design
- (2014) Maria Soto et al. INTERNATIONAL PSYCHOGERIATRICS
- Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition
- (2014) Jeffrey Cummings et al. INTERNATIONAL PSYCHOGERIATRICS
- Effect of Citalopram on Agitation in Alzheimer Disease
- (2014) Anton P. Porsteinsson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of Neuropsychiatric Symptoms of Dementia in Clinical Settings: Recommendations from a Multidisciplinary Expert Panel
- (2014) Helen C. Kales et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- An Antidepressant Decreases CSF A Production in Healthy Individuals and in Transgenic AD Mice
- (2014) Y. I. Sheline et al. Science Translational Medicine
- Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
- (2014) Ester Aso et al. Frontiers in Pharmacology
- Aripiprazole in the treatment of Alzheimer's disease
- (2013) Peter Paul De Deyn et al. EXPERT OPINION ON PHARMACOTHERAPY
- Safety and efficacy of ORM-12741 on cognitive and behavioral symptoms in patients with Alzheimer's disease: A randomized, double-blind, proof-of-concept study
- (2013) J.O. Rinne et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Association of Stroke with the Receptor-Binding Profiles of Antipsychotics—A Case-Crossover Study
- (2012) Chi-Shin Wu et al. BIOLOGICAL PSYCHIATRY
- Nonpharmacologic Management of Behavioral Symptoms in Dementia
- (2012) Laura N. Gitlin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Effects of ELND005 (Scyllo-Inositol) on Emergence of Neuropsychiatric Symptoms (NPS) in Mild/Moderate Alzheimer's Disease: Results from a 78-Week Phase 2 Study (P04.215)
- (2012) P. Tariot et al. NEUROLOGY
- Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults
- (2011) Alicia Ruelaz Maher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- (2011) S. Salloway et al. NEUROLOGY
- Serotonin signaling is associated with lower amyloid- levels and plaques in transgenic mice and humans
- (2011) J. R. Cirrito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cerebrovascular Accidents in Elderly People Treated with Antipsychotic Drugs
- (2010) Emilio Sacchetti et al. DRUG SAFETY
- Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
- (2010) Martin J O'Donnell et al. LANCET
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Elderly Patients With Dementia-Related Symptoms of Severe Agitation and Aggression
- (2009) Carl Salzman et al. JOURNAL OF CLINICAL PSYCHIATRY
- Risk Factors for Ischaemic Stroke
- (2008) Claire L. Allen et al. International Journal of Stroke
- A Randomized, Double-Blind, Placebo-Controlled Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients With Alzheimer's, Vascular, or Mixed Dementia
- (2008) S RAPPAPORT et al. Journal of the American Medical Directors Association
- Consistency of Neuropsychiatric Syndromes across Dementias: Results from the European Alzheimer Disease Consortium
- (2007) Pauline Aalten et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation